CC — The Chemours Company

Chemours Company Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Adjusted EBITDA: Exceeded expectations, driven by strong performance in the TSS segment and lower corporate costs.
• TSS Segment: Achieved record Opteon Refrigerants sales with an 80% year-over-year increase, contributing to a 35% adjusted EBITDA margin.
• APM Segment: Earnings met expectations, supported by operational recovery at Washington Works.
• TT Segment: Results fell below expectations due to macroeconomic weakness in the TiO2 market, with sequential sales expected to decline in the high single digits to low teens percentage range.
• Consolidated Guidance: Q4 net sales anticipated to decrease by 10% to 15%, with adjusted EBITDA projected between $130 million and $160 million. Full-year 2025 sales expected between $5.7 billion and $5.8 billion, with adjusted EBITDA of $745 million to $770 million.

2. Strategic Updates and Business Highlights:

• Pathway to Thrive Strategy: Progress reported across all pillars, including operational excellence and portfolio management.
• TSS Business: Focus on maximizing value from quota allowances and capturing sales opportunities amid the U.S. AIM Act transition.
• Critical Minerals: Estimated $90 million in annual sales, with government funding of approximately $10 million awarded for 2025 and 2026 to support separation capabilities.
• Operational Improvements: Established a manufacturing center of excellence to enhance reliability and efficiency.

3. Forward Guidance and Outlook:

• TSS Segment: Anticipates continued double-digit growth in Opteon sales into early 2026, despite expected sequential declines in Q4.
• APM Segment: Forecasts low single-digit sequential sales decline, with adjusted EBITDA expected to normalize between $30 million and $40 million in Q4.
• TT Segment: Expects continued challenges with a focus on aligning production with demand, with a projected EBITDA decline of $15 million to $20 million.
• 2026 Outlook: Anticipates overall sales and earnings growth, with improved cash flow performance supported by ongoing cost reduction efforts.

4. Bad News, Challenges, or Points of Concern:

• TT Segment Weakness: Sustained macroeconomic challenges and destocking in the TiO2 market led to disappointing results and lower guidance.
• Operational Disruptions: Previous operational issues impacted performance, although management expressed confidence in resolving these moving forward.
• Market Conditions: Competitive pressures from inventory liquidation by competitors like Venator and ongoing global demand weakness may hinder pricing power and profitability.
• Regulatory Risks: Potential impacts from government shutdowns affecting EPA-related activities and HFO transitions.

5. Notable Q&A Insights:

• TSS Growth Confidence: Management emphasized strong commercial execution and diverse portfolio to mitigate potential volume slowdowns in HVAC OEMs.
• Operational Improvements: Assurance that operational disruptions are largely resolved, with plans for continued enhancements in reliability and efficiency.
• Market Share Strategy: Focus on growing share in fair trade markets, particularly in light of competitor challenges in Europe, India, and Brazil.
• Future Pricing Strategies: Confidence in implementing price increases in TiO2 despite weak demand, supported by fair trade market stability.
• Critical Minerals Potential: Highlighted the strategic importance of critical minerals and government support for future growth opportunities.

Overall, Chemours demonstrated resilience in its TSS segment while facing challenges in the TT segment, with a strategic focus on operational excellence and portfolio optimization to drive future growth.